Register Login
Register to leave comments
  • News bot Aug. 14, 2026, 8:14 p.m.

    📋 JASPER THERAPEUTICS, INC. (JSPR) - Financial Results

    Filing Date: 2026-08-14

    Accepted: 2026-08-14 16:07:42

    Event Type: Financial Results

    Event Details:

    JASPER THERAPEUTICS, INC. (JSPR) Reports the reporting period Financial Results JASPER THERAPEUTICS, INC. (JSPR) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 7314
      • expected in the fourth quarter of 2026
      • targeting both the alternative and terminal pathways within the complement cascade for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and high unmet need nephrology disorders. KP-104 is currently being evaluated in a Phase 2 basket trial in rare renal indications and interim data from Stage 1 of the trial is expected in the fourth quarter of 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 27.08K 20.16K $6.92K +34.31%
    Operating Expenses Interest Income 437.00 246.00 $191.00 +77.64%
    Operating Expenses Total Other Income Expense 84.00 2.36K $-2.27K -96.44%
    Assetscurrent Assets Prepaid Expenses Other Current Assets 3.84K 5.95K $-2.11K -35.49%
    Assetscurrent Assets Property Equipment Net 60.00 102.00 $-42.00 -41.18%
    Assetscurrent Assets Operating Lease Right Of Use Assets 128.00 502.00 $-374.00 -74.50%
    Current Liabilities Accounts Payable 2.78K 6.22K $-3.44K -55.34%
    Loss from Operations 9.21K 27.08K $-17.87K -66.00%
    Interest Income 82.00 437.00 $-355.00 -81.24%
    Other Income, Net 6.45K 353.00 $6.09K +1726.35%
    Net Loss 2.76K 26.72K $-23.96K -89.67%
    Prepaid Expenses and Other Current Assets 3.84K 5.95K $-2.11K -35.49%
    Property and Equipment, Net 60.00 102.00 $-42.00 -41.18%
    Accounts Payable 2.78K 6.22K $-3.44K -55.34%
    Operating Lease Liabilities 270.00 1.24K $-965.00 -78.14%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: JASPER THERAPEUTICS, INC.
    • Ticker Symbol: JSPR

Search

News categories